Seamless Phase II-Phase III Randomized Clinical Trial to Identify and Confirm the Most Promising Novel Intervention to Alleviate Morbidity and…
A Multi-Center, Phase II Trial of HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide
This…
This study is for patients that have a type of lymph gland disease called Hodgkin or non-Hodgkin Lymphoma or T/NK-lymphoproliferative disease which…
Pilot study examining multiple physical and psychological outcomes in adolescent girls and young women, age 10-24 years, who are long-term cancer…
Patients may be considered if the cancer has come back, has not gone away after standard treatment or the patient cannot receive standard treatment.…
This phase II trial tests whether treosulfan, fludarabine, and rabbit antithymocyte globulin (rATG) work when given before a blood or bone marrow…
Investigators have previously used this sort of therapy to treat Hodgkin or non-Hodgkin lymphoma that is associated with the virus that causes…
Ex Vivo T-Cell Depletion of Mobilized peripheral blood stem cells via CD34-Selection
Participants are being asked to take part in this study…
Cell Therapy for High Risk T-cell Malignancies using CD7-Specific CAR Expressed on Non-Edited T cells (CRIMSON-NE)
Patients eligible for this study…
Phase I study of HER2 chimeric antigen receptor (CAR) T cells in combination with checkpoint blockade in patients with advanced sarcoma (HEROS 3.0)…